Focusing on small to mid-size, research-based biopharmaceutical, academic or entrepreneurial groups/companies, Modoc approaches each group/company’s drug development as a strategic partnership – helping you reach your goal and ease the process, not hinder it – Modoc wants to be your partner!

We know that with our vision we can help you embrace your future by providing the most streamlined and cost-effective approach to obtaining your goal of a successful project whether it be taking a compound to full approval or seeing a compound carried through proof-of-concept (PoC)/early phase studies we know that your future is dependent on the strength of the team we put together. 

IND NDA: Establish a project team for your pre-clinical drug development from compound selection to IND filing – work with a network of strategic partners and collaborative consultants to bring your compound through the IND process with time-savings and optimal resource utilization.  

505(b)(2) NDA:  As the number of 505 (b)(2) drug approvals increasing, many sponsors are finding this strategy to drug development to be very pragmatic.  To increase the likelihood for successful filing and registration, an effective partnership is needed to prepare a comprehensive plan.

Regardless of the route your project takes, you will find the experience and resources needed to guide you through every aspect of early phase development when you partner with Modoc.